ONLINE DATABASE SEARCH - HIV-LS-335-MEMO
1. 48084 HIV-LS-335; PUBMED-HIV-11/14/2005
Effect of Cell Cycle Arrest on the Activity of Nucleoside Analogues against Human Immunodeficiency Virus Type 1
Wurtzer, S, Compain, S, Benech, H, Hance, AJ, and Clavel, F
J Virol 2005. 79(23): 14815-14821
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16282481&dopt=abstract
2. 48085 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Preparation of carbocyclic cyclopropyl nucleoside phosphonate derivatives useful in the treatment of HIV infections
Averett, Devron R
PATENT: WO 2005079812 ISSUE DATE: 20050901
APPLICATION: 2005 PP: 97 pp.
ASSIGNEE: (Anadys Pharmaceuticals, Inc. USA
3. 48086 HIV-LS-335; PUBMED-HIV-11/14/2005
Synthesis and Biological Activity of Novel Acyclic Versions of NeplanocinA
Wu, Y and Hong, JH
Arch Pharm (Weinheim) 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16281309&dopt=abstract
4. 48087 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Research on anti-HIV activity of polytungstate
Li, Li and Lu, Xiaoming
Huaxue Tongbao 2005. 68(6): 438-443
5. 48088 HIV-LS-335; PUBMED-HIV-11/14/2005
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity
Fattorusso, C, Gemma, S, Butini, S, Huleatt, P, Catalanotti, B, Persico, M, De, Angelis M, Fiorini, I, Nacci, V, Ramunno, A, Rodriquez, M, Greco, G, Novellino, E, Bergamini, A, Marini, S, Coletta, M, Maga, G, Spadari, S, and Campiani, G
J Med Chem 2005. 48(23): 7153-7165
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16279773&dopt=abstract
6. 48089 HIV-LS-335; PUBMED-HIV-11/14/2005
Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles
Peretti, S, Schiavoni, I, Pugliese, K, and Federico, M
Virology 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16271741&dopt=abstract
7. 48090 HIV-LS-335; PUBMED-HIV-11/14/2005
New trends in synthesis of pyrazole nucleosides as new antimetabolites
Elgemeie, GH, Zaghary, WA, Amin, KM, and Nasr, TM
Nucleosides Nucleotides Nucleic Acids 2005. 24(8): 1227-47
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16270665&dopt=abstract
8. 48091 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Use of human b defensin or its inducing agents for treating HIV-1 assocd. with chemokine receptor CXCR4
Weinberg, Aaron
PATENT: US 2005075292 ISSUE DATE: 20050407
APPLICATION: 2004-39857 PP: 47 pp., Cont.-in-part of U.S. Ser. No. 737,288.
ASSIGNEE: (Case Western Reserve University, USA
9. 48092 HIV-LS-335; PUBMED-HIV-11/14/2005
Case history: Acyclic nucleoside phosphonates: a key class of antiviral drugs
De Clercq, E and Holy, A
Nat Rev Drug Discov 2005. 4(11): 928-940
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16264436&dopt=abstract
10. 48093 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Preparation of 2-aminobenzimidazoles for the treatment of HIV/AIDS
Schohe-Loop, Rudolf, Paessens, Arnold, Bauser, Marcus, Koebberling, Johannes, Dittmer, Frank, Henninger, Kerstin, Lang, Dieter, and Paulsen, Daniela
PATENT: WO 2005019186 ISSUE DATE: 20050303
APPLICATION: 2004 PP: 59 pp.
ASSIGNEE: (Bayer Healthcare A.-G., Germany
11. 48094 HIV-LS-335; PUBMED-HIV-11/14/2005
Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase
Jorgensen, WL, Ruiz-Caro, J, Tirado-Rives, J, Basavapathruni, A, Anderson, KS, and Hamilton, AD
Bioorg Med Chem Lett 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16263277&dopt=abstract
12. 48095 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Preparation of ethynyl 4'-C-substituted-2-halo-adenosine derivatives as antiviral agents
Kohgo, Satoru, Mitsuya, Hiroaki, Ohrui, Hiroshi, Kodama, Eiichi, and Matsuoka, Masao
PATENT: CA 2502109 ISSUE DATE: 20050924
APPLICATION: 2005 PP: 71 pp.
ASSIGNEE: (Yamasa Corporation, Japan
13. 48096 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
Herdewijn, Piet, Pannecouque, Christophe, Wu, Tongfei, and De Clercq, Erik
PATENT: WO 2005085268 ISSUE DATE: 20050915
APPLICATION: 2005 PP: 134 pp.
ASSIGNEE: (K. U. Leuven Research & Development, Belg.
14. 48097 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication
Heredia, Alonso, Davis, Charles, Bamba, Douty, Le, Nhut, Gwarzo, Muhammad Y, Sadowska, Mariola, Gallo, Robert C, and Redfield, Robert R
AIDS (London, United Kingdom) 2005. 19(18): 2087-2095
15. 48098 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites
Gerhaeuser, Clarissa
Molecular Nutrition & Food Research 2005. 49(9): 827-831
16. 48099 HIV-LS-335; SCIFINDER-HIV-11/15/2005
HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G
Kremer, Melanie and Schnierle, Barbara S
Current HIV Research 2005. 3(4): 339-344
17. 48100 HIV-LS-335; PUBMED-HIV-11/14/2005
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors
Barreca, ML, Ferro, S, Rao, A, De Luca, L, Zappala, M, Monforte, AM, Debyser, Z, Witvrouw, M, and Chimirri, A
J Med Chem 2005. 48(22): 7084-7088
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16250669&dopt=abstract
18. 48101 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Synthesis and antiviral activity of 1-{[2-(phenoxy)ethoxy]methyl}uracil derivatives
Novikov, MS, Ozerov, AA, Orlova, YuA, and Buckheit, RW
Chemistry of Heterocyclic Compounds (New York, NY, United States) 2005. 41(5): 625-629
19. 48102 HIV-LS-335; PUBMED-HIV-11/14/2005
Synthesis of 2'-C-methyl-beta-D-ribofuranosylimidazo [4,5-d]-pyridazine derivatives (2-aza-3-deazapurine nucleoside analogues)
Leroy, F, Dukhan, D, Durka, M, Chaves, D, Bragnier, N, Storer, R, and Gosselin, G
Nucleosides Nucleotides Nucleic Acids 2005. 24(5-7): 667-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16248010&dopt=abstract
20. 48103 HIV-LS-335; PUBMED-HIV-11/14/2005
Homo and heterodimers of ddI, d4T and AZT: influence of (5'-5') thiolcabonate-carbamate linkage on anti-HIV activity
Taourirte, M, Lazrek, HB, Rochdi, A, Vasseur, JJ, and Engels, JW
Nucleosides Nucleotides Nucleic Acids 2005. 24(5-7): 523-5
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16247983&dopt=abstract
21. 48104 HIV-LS-335; PUBMED-HIV-11/14/2005
Borano-nucleotides: new analogues to circumvent HIV-1 RT-mediated nucleoside drug-resistance
Alvarez, K, Deval, J, Selmi, B, Barral, K, Boretto, J, Guerreiro, C, Mulard, L, Sarfati, R, and Canard, B
Nucleosides Nucleotides Nucleic Acids 2005. 24(5-7): 419-21
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16247962&dopt=abstract
22. 48105 HIV-LS-335; PUBMED-HIV-11/14/2005
Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs
Brown, D, Arzumanov, AA, Turner, JJ, Stetsenko, DA, Lever, AM, and Gait, MJ
Nucleosides Nucleotides Nucleic Acids 2005. 24(5-7): 393-6
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16247957&dopt=abstract
23. 48106 HIV-LS-335; PUBMED-HIV-11/14/2005
Tipranavir (Aptivus) for HIV
Anon
Med Lett Drugs Ther 2005. 47(1219): 83-84
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16247341&dopt=abstract
24. 48107 HIV-LS-335; SCIFINDER-HIV-11/15/2005
Cytotoxicity and antiviral activity of a lignan extracted from Larrea divaricata
Konigheim, BS, Goleniowski, ME, and Contigiani, MS
Drug Design Reviews--Online 2005. 2(1): 81-83
25. 48108 HIV-LS-335; PUBMED-HIV-11/14/2005
A short synthetic route to biologically active (+/-)-daurichromenic acid as highly potent anti-HIV agent
Rok, Lee Y and Wang, X
Org Biomol Chem 2005. 3(21): 3955-7
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16240013&dopt=abstract
26. 48109 HIV-LS-335; PUBMED-HIV-11/14/2005
Inhibition of HIV-1 group M and O isolates by fusion inhibitors
Chinnadurai, R, Munch, J, Dittmar, MT, and Kirchhoff, F
AIDS 2005. 19 (16): 1919-22
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16227804&dopt=abstract
27. 48110 HIV-LS-335; PUBMED-HIV-11/14/2005
Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry
Dickinson, L, Robinson, L, Tjia, J, Khoo, S, and Back, D
J Chromatogr B Analyt Technol Biomed Life Sci 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16226495&dopt=abstract
28. 48111 HIV-LS-335; WOS-HIV-11/6/2005
Statins could be used to control replication of some viruses, including HIV-1
Gilbert, C, Bergeron, M, Methot, S, Giguere, JF, and Tremblay, MJ
VIRAL IMMUNOLOGY 2005. 18(3): 474-489, 16
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232733600009
29. 48112 HIV-LS-335; WOS-HIV-11/6/2005
One-pot synthesis of aryl phosphoramidate derivatives of AZT/d4T as anti-HIV prodrugs
Jiang, P, Guo, J, Fu, H, Jiang, YY, and Zhao, YF
SYNLETT 2005.(16): 2537-2539, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232736100035
30. 48113 HIV-LS-335; WOS-HIV-11/6/2005
Synthesis of 8-chloro-5,5-dioxo[1,2,4]triazolo[4,3-b] [1,4,2]benzodithiazine derivatives with potential anticancer and anti-HIV-1 activities
Brzozowski, Z and Saczewski, F
POLISH JOURNAL OF CHEMISTRY 2005. 79(10): 1659-1666, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232589600011
31. 48114 HIV-LS-335; WOS-HIV-11/6/2005
New acyclonucleosides: Synthesis and anti-HIV activity
Hadj-Bouazza, A, Zerrouki, R, Krausz, P, Laumond, G, Aubertin, AM, and Champavier, Y
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2005. 24(8): 1249-1263, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232691900008
32. 48115 HIV-LS-335; WOS-HIV-11/6/2005
Synthesis of novel acyclonucleosides analogs of pyridothienopyrimidine as antiviral agents
El-Essawy, FA
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2005. 24(8): 1265-1276, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232691900009
33. 48116 HIV-LS-335; WOS-HIV-11/6/2005
Biologically active bisbenzylisoquinoline alkaloids from the root bark of Epinetrum villosum
Otshudi, AL, Apers, S, Pieters, L, Claeys, M, Pannecouque, C, De Clercq, E, Van Zeebroeck, A, Lauwers, S, Frederich, M, and Foriers, A
JOURNAL OF ETHNOPHARMACOLOGY 2005. 102(1): 89-94, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232709800012
34. 48117 HIV-LS-335; WOS-HIV-11/6/2005
Isolation, synthesis and biological activity of grifolic acid derivatives from the inedible mushroom Albatrellus dispansus
Hashimoto, T, Quang, DN, Nukada, M, and Asakawa, Y
HETEROCYCLES 2005. 65(10): 2431-2439, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232582400010
35. 48118 HIV-LS-335; WOS-HIV-11/6/2005
Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir
Le Tiec, C, Barrail, A, Goujard, U, and Taburet, AM
CLINICAL PHARMACOKINETICS 2005. 44(10): 1035-1050, 16
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232788400003
36. 48119 HIV-LS-335; WOS-HIV-11/6/2005
Synthesis and anti-HIV activity of trisubstituted (3 ' R, 4 ' R)-3 ',4 '-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs
Zhao, CH, Zhou, T, Xie, L, Li, JY, Bao, ZY, Lou, ZW, and Lee, KH
CHINESE CHEMICAL LETTERS 2005. 16(10): 1297-1300, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232638500006
37. 48120 HIV-LS-335; WOS-HIV-11/6/2005
HIV cohort collaborations: proposal for harmonization of data exchange
Kjaer, J and Ledergerber, B
ANTIVIRAL THERAPY 2004. 9(4): 631-633, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600020
38. 48121 HIV-LS-335; WOS-HIV-11/6/2005
Novel small-molecule compounds which inhibit strand transfer activity of HIV-1 integrase
Yan, H, Chiba, T, Kitamura, Y, Nishizawa, M, Fujino, M, Yamamoto, N, and Sugiura, W
ANTIVIRAL THERAPY 2004. 9(4): U23-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600026
39. 48122 HIV-LS-335; WOS-HIV-11/6/2005
In vitro development of resistance against styrylquinolines of HIV-1 by emergence of integrase mutations
Bonnenfant, S, Zouhiri, F, Cheret, A, and Leh, H
ANTIVIRAL THERAPY 2004. 9(4): U24-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600027
40. 48123 HIV-LS-335; WOS-HIV-11/6/2005
In vitro selection and characterization of resistance to the new HIV protease inhibitor GW640385
Yates, P, Hazen, R, St, Clair M, Boone, L, and Elston, R
ANTIVIRAL THERAPY 2004. 9(4): U28-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600036
41. 48124 HIV-LS-335; WOS-HIV-11/6/2005
Antiviral activity and resistance profile of AG-001859, a novel HIV-1 protease inhibitor with potent activity against protease inhibitor-resistant strains of HIV
Hammond, J, Jackson, L, Graham, J, Knowles, S, Digits, J, Tatlock, J, Jewell, T, Canan-Koch, S, and Patick, AK
ANTIVIRAL THERAPY 2004. 9(4): U29-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600037
42. 48125 HIV-LS-335; WOS-HIV-11/6/2005
Highly potent HIV protease inhibitors with broad activity against MDR strains
Gulnik, SV, Afonina, E, Yu, B, Eissenstat, M, Guerassina, T, Silva, AM, and Erickson, JW
ANTIVIRAL THERAPY 2004. 9(4): U29-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600038
43. 48126 HIV-LS-335; WOS-HIV-11/6/2005
Mutations in HIV-1 RNase H domain confer high-level resistance to nucleoside reverse transcriptase inhibitors and provide novel insights into the mechanism of nucleotide excision-mediated drug resistance
Nikolenko, GN, Palmer, S, Maldarelli, F, Mellors, JW, Coffin, JM, and Pathak, VK
ANTIVIRAL THERAPY 2004. 9(4): U35-U36, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600044
44. 48127 HIV-LS-335; WOS-HIV-11/6/2005
Dinucleoside polyphosphates are novel inhibitors of HIV-1 reverse transcriptase with increased potency against enzymes containing AZT-resistance mutations
Meyer, P, Smith, A, Matsuura, S, and Scott, W
ANTIVIRAL THERAPY 2004. 9(4): U41-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600055
45. 48128 HIV-LS-335; WOS-HIV-11/6/2005
Susceptibility to saquinavir and atazanavir in highly protease inhibitor (PI) resistant HIV-1 is caused by lopinavir-induced drug resistance mutation L76V
Mueller, SM, Daeumer, M, Kaiser, R, Walter, H, Colonno, R, and Korn, K
ANTIVIRAL THERAPY 2004. 9(4): U44-U45, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600062
46. 48129 HIV-LS-335; WOS-HIV-11/6/2005
No evidence for stavudine resistance due to nevirapine-selected mutation Y181C in HIV-1 reverse transcriptase in a large genotype/phenotype database
Korn, K, Schmidt, B, and Walter, H
ANTIVIRAL THERAPY 2004. 9(4): U47-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600067
47. 48130 HIV-LS-335; WOS-HIV-11/6/2005
A novel method based on recombinant viruses expressing green (EGFP) or red (DsRED) fluorescent proteins to study replicative fitness evolution of nelfinavir-resistant HIV-1 harbouring D30N and L90M mutations in the protease gene
Weber, J, Weberova, J, Kiser, P, Kazanjian, P, and Quinones-Mateu, M
ANTIVIRAL THERAPY 2004. 9(4): U55-U56, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600077
48. 48131 HIV-LS-335; WOS-HIV-11/6/2005
Replicative fitness of HIV-1 strains with reduced susceptibility to protease-, reverse transcriptase and entry (enfuvirtide)-inhibitors
Chakraborty, B, Weber, J, and Quinones-Mateu, ME
ANTIVIRAL THERAPY 2004. 9(4): U59-U60, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600085
49. 48132 HIV-LS-335; WOS-HIV-11/6/2005
Previously unclassified mutations at positions experienced treatment failure associated with antiretroviral drug resistance
Rhee, SY, Hurley, L, Zolopa, A, Fessel, WJ, Nguyen, DP, Slome, S, Smith, S, Klein, D, Horberg, M, Flamm, J, Follansbee, S, and Shafer, RW
ANTIVIRAL THERAPY 2004. 9(4): U109-U110, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231615600164
50. 48133 HIV-LS-335; WOS-HIV-11/6/2005
Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1)
Cono-Soldodo, P, Larrayoz, IM, Molina-Arcas, M, Casado, FJ, Martinez-Picado, J, Lostao, MP, and Pastor-Anglada, M
ANTIVIRAL THERAPY 2004. 9(6): 993-1002, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231616000016
51. 48134 HIV-LS-335; WOS-HIV-11/6/2005
Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals
Costagliola, D, Potard, V, Duvivier, C, Pradier, C, Dupont, C, Salmon, D, and Duval, X
ANTIVIRAL THERAPY 2005. 10(4): 563-573, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100012
52. 48135 HIV-LS-335; WOS-HIV-11/6/2005
Relation between the antiretroviral activity of didanosine (ddI) and the number of reverse tran-scriptase (RT) mutations: dINAM study
Blanco, JL, Biglia, A, Arnedo, M, de Lazzari, E, Mallolas, J, Martinez, E, Lonca, M, Laguno, M, Larrousse, M, Leon, A, Milinkovic, A, Garcia, F, Miro, JM, Arnaiz, J, Pumarola, T, and Gatell, JM
ANTIVIRAL THERAPY 2005. 10(4): S26-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100040
53. 48136 HIV-LS-335; WOS-HIV-11/6/2005
Divalent metal ion chelating small molecules as novel HIV integrase inhibitors
Jegede, O, Weber, J, Rajagopalan, R, Wawro, WJ, Babu, JS, and Quinones-Mateu, ME
ANTIVIRAL THERAPY 2005. 10(4): S83-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100092
54. 48137 HIV-LS-335; WOS-HIV-11/6/2005
An HIV-1 RNase H inhibitor synergizes with three different classes of RT polymerase inhibitors in an in vitro reverse transcription assay
Miller, MD, Feuston, B, Munshi, V, Getty, K, Krueger, J, Hazuda, DJ, Parniak, MA, Lewis, D, Grobler, JA, and Shaw-Reid, CA
ANTIVIRAL THERAPY 2005. 10(4): S90-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100096
55. 48138 HIV-LS-335; WOS-HIV-11/6/2005
Substrate dependent inhibition or activation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Hang, JO, Yang, Y, Li, Y, Tsing, S, Barnett, J, Cammack, N, and Klumpp, K
ANTIVIRAL THERAPY 2005. 10(4): S97-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100103
56. 48139 HIV-LS-335; WOS-HIV-11/6/2005
Role of HIV-1 protease residues 71 and 89 in protease inhibitor resistance of subtype G viruses
Gonzalez, LMF, Van Laethem, K, Abecasis, AB, Soares, EAJM, Deforche, K, Vandamme, AM, Camacho, R, and Soares, MA
ANTIVIRAL THERAPY 2005. 10(4): S112-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100118
57. 48140 HIV-LS-335; WOS-HIV-11/6/2005
Selection of resistance following first-line antiretroviral regimens among HIV-1 subtypes
Kantor, R, DeLong, A, Shafer, RW, Carvalho, AP, Wynhoven, B, Cane, P, Sirivichayakul, S, Soares, MA, Snoeck, J, Rudich, H, Rodrigues, R, Holguin, A, Ariyoshi, K, Bouzas, MB, Cahn, P, Sugiura, W, Soriano, V, Brigido, LF, Grossman, Z, Morris, L, Vandamme, AM, Tanuri, A, Phanuphak, P, Weber, J, Pillay, D, Harrigan, PR, Camacho, R, Schapiro, JM, Hogan, J, and Katzenstein, DA
ANTIVIRAL THERAPY 2005. 10(4): S146-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100149
58. 48141 HIV-LS-335; WOS-HIV-11/6/2005
Reversion of drug resistant HIV protease mutants is prohibited by a reduction in replication capacity of the intermediate variants
van Maarseveen, NM, Wensing, AMJ, de Jong, D, Taconis, M, Boucher, CAB, and Nijhuis, M
ANTIVIRAL THERAPY 2005. 10(4): S161-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100162
59. 48142 HIV-LS-335; WOS-HIV-11/6/2005
In vitro microbicide activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant HIV-1
Hossain, MM and Parniak, MA
ANTIVIRAL THERAPY 2005. 10(4): S170-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231963100171
60. 48143 HIV-LS-335; WOS-HIV-11/6/2005
Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir
Doyon, L, Tremblay, S, Bourgon, L, Wardrop, E, and Cordingley, MG
ANTIVIRAL RESEARCH 2005. 68(1): 27-35, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232672600004
61. 48144 HIV-LS-335; WOS-HIV-11/6/2005
First-line antiretroviral therapy in Africa - How evidence-based are our recommendations?
Colebunders, R, Kamya, MR, Laurence, J, Kambugu, A, Byakwaga, H, Mwebaze, PS, Muganga, AM, Katwere, M, and Katabira, E
AIDS REVIEWS 2005. 7(3): 148-154, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232700900003
62. 48145 HIV-LS-335; WOS-HIV-11/13/2005
Ester derivatives of nucleoside inhibitors of reverse transcriptase: 2. Molecular systems for the combined therapy with 3 '-azido-3 '-deoxythymidine and 2 ',3 '-didehydro-3 '-deoxythymidine
Berezovskaya, YV and Chudinov, MV
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2005. 31(5): 405-418, 14
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232932200001
63. 48146 HIV-LS-335; WOS-HIV-11/13/2005
Synthesis, conformation and antiviral activity of nucleoside analogues with the (2-hydroxy-1-phenylethoxy) methyl glycone - a family of nucleoside analogues related to d4T and aciclovir
Ewing, DF, Glacon, V, Len, C, and Mackenzie, G
NEW JOURNAL OF CHEMISTRY 2005. 29(11): 1461-1468, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232846000016
64. 48147 HIV-LS-335; WOS-HIV-11/13/2005
Study of potential HIV-1 inhibition. Glutaric dialdehyde adducts
Jankowski, CK, Martel, J, Fermandjian, S, and Maroun, RG
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM 2005. 731(1-3): 83-87, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232847400011
65. 48148 HIV-LS-335; WOS-HIV-11/13/2005
Hydroxyethylene sulfones as a new scaffold to address aspartic proteases: Design, synthesis, and structural characterization
Specker, E, Bottcher, J, Heine, A, Sotriffer, CA, Lilie, H, Schoop, A, Muller, G, Griebenow, N, and Klebe, G
JOURNAL OF MEDICINAL CHEMISTRY 2005. 48(21): 6607-6619, 13
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232781600009
66. 48149 HIV-LS-335; WOS-HIV-11/13/2005
Novel approaches in designing anti-HIV microbicides and anti-HIV agents - Editorial
Parang, K
CURRENT PHARMACEUTICAL DESIGN 2005. 11(29): 1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232839600001
67. 48150 HIV-LS-335; WOS-HIV-11/13/2005
Indolyl aryl Sulfones (IASs): Development of highly potent NNRTIs active against wt-HIV-1 and clinically relevant drug resistant mutants
Silvestri, R and Artico, M
CURRENT PHARMACEUTICAL DESIGN 2005. 11(29): 3779-3806, 28
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232839600006
68. 48151 HIV-LS-335; WOS-HIV-11/13/2005
Synthesis and antiviral activity of novel anomeric branched carbocyclic nucleosides
Kim, A and Hong, JH
ARCHIVES OF PHARMACAL RESEARCH 2005. 28(10): 1105-1110, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000232930100001